Comparing the Value of Data Visualization Methods for Communicating Harms in Clinical Trials

In clinical trials, harms (i.e., adverse events) are often reported by simply counting the number of people who experienced each event. Reporting only frequencies ignores other dimensions of the data that are important for stakeholders, including severity, seriousness, rate (recurrence), timing, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Qureshi, Riaz, Chen, Xiwei, Goerg, Carsten, Mayo-Wilson, Evan, Dickinson, Stephanie, Golzarri-Arroyo, Lilian, Hong, Hwanhee, Phillips, Rachel, Cornelius, Victoria, McAdams DeMarco, Mara, Guallar, Eliseo, Li, Tianjing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780120/
https://www.ncbi.nlm.nih.gov/pubmed/36065832
http://dx.doi.org/10.1093/epirev/mxac005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780120/
https://www.ncbi.nlm.nih.gov/pubmed/36065832
http://dx.doi.org/10.1093/epirev/mxac005

Ejemplares similares